1982
DOI: 10.1172/jci110696
|View full text |Cite
|
Sign up to set email alerts
|

Neutralization of Epstein-Barr Virus by Nonimmune Human Serum

Abstract: A B S T R A C T These studies were carried out to investigate the mechanism of neutralization of purified Epstein-Barr virus (EBV) simplex I (HSV-1) absorbed the EBV ELISA reactivity and EBV-neutralizing activity of nonimmune sera, whereas another member of the herpesvirus group, cytomegalovirus, was inactive in this regard. HSV-1 was quantitatively more efficient than EBV in absorbing reactivity, a finding that indicates that the antibody has a higher affinity for HSV-1 than for EBV. Further absorption st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

1984
1984
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(9 citation statements)
references
References 48 publications
1
7
0
Order By: Relevance
“… 34 36 In addition, complement-enhancing neutralization without virolysis has been described, and one proposed mechanism for this is that the accumulation of complement on viral envelop would inhibit viral interaction with its cellular receptor required for viral entry. 28 , 37 Our data were consistent with this proposed mechanism, and our results further indicated that this mechanism could be affected by the antibodies’ biochemical properties, including epitope specificity. The antibodies in our study exhibited different neutralizing profiles in the presence of complement and different patterns in Western blot analysis.…”
Section: Discussionsupporting
confidence: 88%
“… 34 36 In addition, complement-enhancing neutralization without virolysis has been described, and one proposed mechanism for this is that the accumulation of complement on viral envelop would inhibit viral interaction with its cellular receptor required for viral entry. 28 , 37 Our data were consistent with this proposed mechanism, and our results further indicated that this mechanism could be affected by the antibodies’ biochemical properties, including epitope specificity. The antibodies in our study exhibited different neutralizing profiles in the presence of complement and different patterns in Western blot analysis.…”
Section: Discussionsupporting
confidence: 88%
“…Complement activation augments antibody-mediated neutralization of several viruses, including influenza [165] , [182] , HIV [183] , [184] , [185] , [186] , respiratory syncytial [187] , [188] , varicella zoster [189] , [190] , [191] , Epstein-Barr [192] , [193] , and herpes simplex viruses [194] , [195] , [196] . Complement also improves antibody-mediated neutralization of Flaviviruses.…”
Section: Complement and Flavivirus Infectionmentioning
confidence: 99%
“…Virus was labelled with [35S]methionine, purified through a tartrate gradient, and diluted to 105 cpm/ml in 1% bovine serum albumin in phosphate-buffered saline (BSA-PBS) before use. Calculated from the DNA contents of the virus (17), the specific activities of the labelled viruses were 2.08 x 10-5 cpm per particle for wt virus, 4.49 x 10-5 cpm per particle for the gIll mutant, and 1.66 x 10-5 cpm per particle for vBPgIII. The viral infectivity levels were 4.29 x 10-4 PFU per particle for the wt virus, 2.69 x 10-' PFU per particle for the glll mutant, and 9.73 x i0-5 PFU per particle for vBPgIII.…”
mentioning
confidence: 99%